Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the selective inhibition of coX-2 (COX-2) to inhibit the production of prostaglandins, achieve anti-inflammatory and analgesic effects.
The drug is used to relieve symptoms and signs of osteoarthritis and rheumatoid arthritis in adults and has fewer gastrointestinal side effects than traditional non-steroidal anti-inflammatory drugs.
This report aims to provide a comprehensive presentation of the global market for Celecoxib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Celecoxib. This report contains market size and forecasts of Celecoxib in global, including the following market information:
Global Celecoxib Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Celecoxib Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Celecoxib companies in 2022 (%)
The global Celecoxib market was valued at US$ 1308.1 million in 2022 and is projected to reach US$ 2247.5 million by 2029, at a CAGR of 8.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Data show that more than 400 million people worldwide are currently affected by joint diseases.
The prevalence of osteoarthritis is 17 percent among people aged 40, 62 percent among people over 60 and 80 percent among people over 75.
The number of patients with arthritis in mainland China is more than 10% of the total population, well over 100 million, and the incidence of arthritis increases with age, and the number of patients is still increasing.
At present, the burden of chronic diseases will increase by 40% due to the aging of the population.
As the population ages, anti-inflammatory and anti-rheumatic drugs will enter a phase of rapid growth.
Globally, whether prescription drugs or non-prescription drugs, Xibu is widely used in clinical practice.
At present, the best seller in the international market is Celixib. Celixib market will continue to grow steadily in the next few years.
At present, the global Celecoxib market is basically occupied by Pfizer, which has formed an oligopoly.
It accounted for 63.39% of the global market in 2019.
As of 2019, China relies entirely on Pfizer for celecoxib imports.
Since 2020, some domestic drug companies have been gradually approved by FDA and CFDA. The introduction of celecoxib generic drugs by local companies will break the monopoly of import.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Celecoxib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Celecoxib Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Celecoxib Market Segment Percentages, by Type, 2022 (%)
- 50mg
- 100mg
- 200mg
- 400mg
Global Celecoxib Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Celecoxib Market Segment Percentages, by Application, 2022 (%)
- Rheumatoid arthritis
- osteoarthritis
- Acute pain
- Musculoskeletal pain
- Other diseases
Global Celecoxib Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Celecoxib Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Celecoxib revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Celecoxib revenues share in global market, 2022 (%)
Key companies Celecoxib sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Celecoxib sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer Inc
- Teva
- Mylan
- Apotex
- Lupin
- Hengrui Medicine
Outline of Major Chapters:
Chapter 1: Introduces the definition of Celecoxib, market overview.
Chapter 2: Global Celecoxib market size in revenue and volume.
Chapter 3: Detailed analysis of Celecoxib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Celecoxib in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Celecoxib capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
Celecoxib Market, Global Outlook and Forecast 2023-2029
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Celecoxib Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Celecoxib Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Celecoxib Overall Market Size
2.1 Global Celecoxib Market Size: 2022 VS 2029
2.2 Global Celecoxib Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Celecoxib Sales: 2018-2029
3 Company Landscape
3.1 Top Celecoxib Players in Global Market
3.2 Top Global Celecoxib Companies Ranked by Revenue
3.3 Global Celecoxib Revenue by Companies
3.4 Global Celecoxib Sales by Companies
3.5 Global Celecoxib Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Celecoxib Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Celecoxib Product Type
3.8 Tier 1, Tier 2 and Tier 3 Celecoxib Players in Global Market
3.8.1 List of Global Tier 1 Celecoxib Companies
3.8.2 List of Global Tier 2 and Tier 3 Celecoxib Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Celecoxib Market Size Markets, 2022 & 2029
4.1.2 50mg
4.1.3 100mg
4.1.4 200mg
4.1.5 400mg
4.2 By Type - Global Celecoxib Revenue & Forecasts
4.2.1 By Type - Global Celecoxib Revenue, 2018-2023
4.2.2 By Type - Global Celecoxib Revenue, 2024-2029
4.2.3 By Type - Global Celecoxib Revenue Market Share, 2018-2029
4.3 By Type - Global Celecoxib Sales & Forecasts
4.3.1 By Type - Global Celecoxib Sales, 2018-2023
4.3.2 By Type - Global Celecoxib Sales, 2024-2029
4.3.3 By Type - Global Celecoxib Sales Market Share, 2018-2029
4.4 By Type - Global Celecoxib Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Celecoxib Market Size, 2022 & 2029
5.1.2 Rheumatoid arthritis
5.1.3 osteoarthritis
5.1.4 Acute pain
5.1.5 Musculoskeletal pain
5.1.6 Other diseases
5.2 By Application - Global Celecoxib Revenue & Forecasts
5.2.1 By Application - Global Celecoxib Revenue, 2018-2023
5.2.2 By Application - Global Celecoxib Revenue, 2024-2029
5.2.3 By Application - Global Celecoxib Revenue Market Share, 2018-2029
5.3 By Application - Global Celecoxib Sales & Forecasts
5.3.1 By Application - Global Celecoxib Sales, 2018-2023
5.3.2 By Application - Global Celecoxib Sales, 2024-2029
5.3.3 By Application - Global Celecoxib Sales Market Share, 2018-2029
5.4 By Application - Global Celecoxib Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Celecoxib Market Size, 2022 & 2029
6.2 By Region - Global Celecoxib Revenue & Forecasts
6.2.1 By Region - Global Celecoxib Revenue, 2018-2023
6.2.2 By Region - Global Celecoxib Revenue, 2024-2029
6.2.3 By Region - Global Celecoxib Revenue Market Share, 2018-2029
6.3 By Region - Global Celecoxib Sales & Forecasts
6.3.1 By Region - Global Celecoxib Sales, 2018-2023
6.3.2 By Region - Global Celecoxib Sales, 2024-2029
6.3.3 By Region - Global Celecoxib Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Celecoxib Revenue, 2018-2029
6.4.2 By Country - North America Celecoxib Sales, 2018-2029
6.4.3 US Celecoxib Market Size, 2018-2029
6.4.4 Canada Celecoxib Market Size, 2018-2029
6.4.5 Mexico Celecoxib Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Celecoxib Revenue, 2018-2029
6.5.2 By Country - Europe Celecoxib Sales, 2018-2029
6.5.3 Germany Celecoxib Market Size, 2018-2029
6.5.4 France Celecoxib Market Size, 2018-2029
6.5.5 U.K. Celecoxib Market Size, 2018-2029
6.5.6 Italy Celecoxib Market Size, 2018-2029
6.5.7 Russia Celecoxib Market Size, 2018-2029
6.5.8 Nordic Countries Celecoxib Market Size, 2018-2029
6.5.9 Benelux Celecoxib Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Celecoxib Revenue, 2018-2029
6.6.2 By Region - Asia Celecoxib Sales, 2018-2029
6.6.3 China Celecoxib Market Size, 2018-2029
6.6.4 Japan Celecoxib Market Size, 2018-2029
6.6.5 South Korea Celecoxib Market Size, 2018-2029
6.6.6 Southeast Asia Celecoxib Market Size, 2018-2029
6.6.7 India Celecoxib Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Celecoxib Revenue, 2018-2029
6.7.2 By Country - South America Celecoxib Sales, 2018-2029
6.7.3 Brazil Celecoxib Market Size, 2018-2029
6.7.4 Argentina Celecoxib Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Celecoxib Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Celecoxib Sales, 2018-2029
6.8.3 Turkey Celecoxib Market Size, 2018-2029
6.8.4 Israel Celecoxib Market Size, 2018-2029
6.8.5 Saudi Arabia Celecoxib Market Size, 2018-2029
6.8.6 UAE Celecoxib Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer Inc
7.1.1 Pfizer Inc Company Summary
7.1.2 Pfizer Inc Business Overview
7.1.3 Pfizer Inc Celecoxib Major Product Offerings
7.1.4 Pfizer Inc Celecoxib Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Inc Key News & Latest Developments
7.2 Teva
7.2.1 Teva Company Summary
7.2.2 Teva Business Overview
7.2.3 Teva Celecoxib Major Product Offerings
7.2.4 Teva Celecoxib Sales and Revenue in Global (2018-2023)
7.2.5 Teva Key News & Latest Developments
7.3 Mylan
7.3.1 Mylan Company Summary
7.3.2 Mylan Business Overview
7.3.3 Mylan Celecoxib Major Product Offerings
7.3.4 Mylan Celecoxib Sales and Revenue in Global (2018-2023)
7.3.5 Mylan Key News & Latest Developments
7.4 Apotex
7.4.1 Apotex Company Summary
7.4.2 Apotex Business Overview
7.4.3 Apotex Celecoxib Major Product Offerings
7.4.4 Apotex Celecoxib Sales and Revenue in Global (2018-2023)
7.4.5 Apotex Key News & Latest Developments
7.5 Lupin
7.5.1 Lupin Company Summary
7.5.2 Lupin Business Overview
7.5.3 Lupin Celecoxib Major Product Offerings
7.5.4 Lupin Celecoxib Sales and Revenue in Global (2018-2023)
7.5.5 Lupin Key News & Latest Developments
7.6 Hengrui Medicine
7.6.1 Hengrui Medicine Company Summary
7.6.2 Hengrui Medicine Business Overview
7.6.3 Hengrui Medicine Celecoxib Major Product Offerings
7.6.4 Hengrui Medicine Celecoxib Sales and Revenue in Global (2018-2023)
7.6.5 Hengrui Medicine Key News & Latest Developments
8 Global Celecoxib Production Capacity, Analysis
8.1 Global Celecoxib Production Capacity, 2018-2029
8.2 Celecoxib Production Capacity of Key Manufacturers in Global Market
8.3 Global Celecoxib Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Celecoxib Supply Chain Analysis
10.1 Celecoxib Industry Value Chain
10.2 Celecoxib Upstream Market
10.3 Celecoxib Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Celecoxib Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Celecoxib in Global Market
Table 2. Top Celecoxib Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Celecoxib Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Celecoxib Revenue Share by Companies, 2018-2023
Table 5. Global Celecoxib Sales by Companies, (K Units), 2018-2023
Table 6. Global Celecoxib Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Celecoxib Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Celecoxib Product Type
Table 9. List of Global Tier 1 Celecoxib Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Celecoxib Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type - Global Celecoxib Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Celecoxib Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Celecoxib Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Celecoxib Sales (K Units), 2018-2023
Table 15. By Type - Global Celecoxib Sales (K Units), 2024-2029
Table 16. By Application - Global Celecoxib Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Celecoxib Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Celecoxib Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Celecoxib Sales (K Units), 2018-2023
Table 20. By Application - Global Celecoxib Sales (K Units), 2024-2029
Table 21. By Region - Global Celecoxib Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Celecoxib Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Celecoxib Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Celecoxib Sales (K Units), 2018-2023
Table 25. By Region - Global Celecoxib Sales (K Units), 2024-2029
Table 26. By Country - North America Celecoxib Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Celecoxib Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Celecoxib Sales, (K Units), 2018-2023
Table 29. By Country - North America Celecoxib Sales, (K Units), 2024-2029
Table 30. By Country - Europe Celecoxib Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Celecoxib Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Celecoxib Sales, (K Units), 2018-2023
Table 33. By Country - Europe Celecoxib Sales, (K Units), 2024-2029
Table 34. By Region - Asia Celecoxib Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Celecoxib Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Celecoxib Sales, (K Units), 2018-2023
Table 37. By Region - Asia Celecoxib Sales, (K Units), 2024-2029
Table 38. By Country - South America Celecoxib Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Celecoxib Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Celecoxib Sales, (K Units), 2018-2023
Table 41. By Country - South America Celecoxib Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Celecoxib Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Celecoxib Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Celecoxib Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Celecoxib Sales, (K Units), 2024-2029
Table 46. Pfizer Inc Company Summary
Table 47. Pfizer Inc Celecoxib Product Offerings
Table 48. Pfizer Inc Celecoxib Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Pfizer Inc Key News & Latest Developments
Table 50. Teva Company Summary
Table 51. Teva Celecoxib Product Offerings
Table 52. Teva Celecoxib Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Teva Key News & Latest Developments
Table 54. Mylan Company Summary
Table 55. Mylan Celecoxib Product Offerings
Table 56. Mylan Celecoxib Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Mylan Key News & Latest Developments
Table 58. Apotex Company Summary
Table 59. Apotex Celecoxib Product Offerings
Table 60. Apotex Celecoxib Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Apotex Key News & Latest Developments
Table 62. Lupin Company Summary
Table 63. Lupin Celecoxib Product Offerings
Table 64. Lupin Celecoxib Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Lupin Key News & Latest Developments
Table 66. Hengrui Medicine Company Summary
Table 67. Hengrui Medicine Celecoxib Product Offerings
Table 68. Hengrui Medicine Celecoxib Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Hengrui Medicine Key News & Latest Developments
Table 70. Celecoxib Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 71. Global Celecoxib Capacity Market Share of Key Manufacturers, 2021-2023
Table 72. Global Celecoxib Production by Region, 2018-2023 (K Units)
Table 73. Global Celecoxib Production by Region, 2024-2029 (K Units)
Table 74. Celecoxib Market Opportunities & Trends in Global Market
Table 75. Celecoxib Market Drivers in Global Market
Table 76. Celecoxib Market Restraints in Global Market
Table 77. Celecoxib Raw Materials
Table 78. Celecoxib Raw Materials Suppliers in Global Market
Table 79. Typical Celecoxib Downstream
Table 80. Celecoxib Downstream Clients in Global Market
Table 81. Celecoxib Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Celecoxib Segment by Type in 2022
Figure 2. Celecoxib Segment by Application in 2022
Figure 3. Global Celecoxib Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Celecoxib Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Celecoxib Revenue, 2018-2029 (US$, Mn)
Figure 7. Celecoxib Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Celecoxib Revenue in 2022
Figure 9. By Type - Global Celecoxib Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Celecoxib Revenue Market Share, 2018-2029
Figure 11. By Type - Global Celecoxib Sales Market Share, 2018-2029
Figure 12. By Type - Global Celecoxib Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Celecoxib Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Celecoxib Revenue Market Share, 2018-2029
Figure 15. By Application - Global Celecoxib Sales Market Share, 2018-2029
Figure 16. By Application - Global Celecoxib Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Celecoxib Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Celecoxib Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Celecoxib Revenue Market Share, 2018-2029
Figure 20. By Region - Global Celecoxib Sales Market Share, 2018-2029
Figure 21. By Country - North America Celecoxib Revenue Market Share, 2018-2029
Figure 22. By Country - North America Celecoxib Sales Market Share, 2018-2029
Figure 23. US Celecoxib Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Celecoxib Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Celecoxib Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Celecoxib Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Celecoxib Sales Market Share, 2018-2029
Figure 28. Germany Celecoxib Revenue, (US$, Mn), 2018-2029
Figure 29. France Celecoxib Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Celecoxib Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Celecoxib Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Celecoxib Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Celecoxib Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Celecoxib Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Celecoxib Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Celecoxib Sales Market Share, 2018-2029
Figure 37. China Celecoxib Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Celecoxib Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Celecoxib Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Celecoxib Revenue, (US$, Mn), 2018-2029
Figure 41. India Celecoxib Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Celecoxib Revenue Market Share, 2018-2029
Figure 43. By Country - South America Celecoxib Sales Market Share, 2018-2029
Figure 44. Brazil Celecoxib Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Celecoxib Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Celecoxib Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Celecoxib Sales Market Share, 2018-2029
Figure 48. Turkey Celecoxib Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Celecoxib Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Celecoxib Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Celecoxib Revenue, (US$, Mn), 2018-2029
Figure 52. Global Celecoxib Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Celecoxib by Region, 2022 VS 2029
Figure 54. Celecoxib Industry Value Chain
Figure 55. Marketing Channels
Global Methylprednisolone Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
Methylprednisolone is a corticosteroid medication used to reduce inflammation and suppress The immune system. It is prescribed for a wide range of medical conditions, including autoimmune disorders and inflammatory diseases.
The global Methylprednisolone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
Methylprednisolone is a widely used medication, and The market trend invol......
Global Ibuprofen Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 84
Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation.
The global Ibuprofen market was valued at US$ 93 million in 2023 and is anticipated to reach US$ 112.3 million by 2030, witnessing a CAGR of 2.7% during The forecast period 2024-2030.
Market competition is intense. Xinhua Pharmaceutical, IOLCP,......
Global Mesalazine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 132
According to our LPI (LP Information) latest study, the global Mesalazine market size was valued at US$ 158.3 million in 2023. With growing demand in downstream market, the Mesalazine is forecast to a readjusted size of US$ 206 million by 2030 with a CAGR of 3.8% during review period.
The research report highlights the growth potential of the global Mesalazine market. Mesalazine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and......
Global Drugs For Sinusitis Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 109
According to our LPI (LP Information) latest study, the global Drugs For Sinusitis market size was valued at US$ 2187.4 million in 2023. With growing demand in downstream market, the Drugs For Sinusitis is forecast to a readjusted size of US$ 2827.4 million by 2030 with a CAGR of 3.7% during review period.
The research report highlights the growth potential of the global Drugs For Sinusitis market. Drugs For Sinusitis are expected to show stable growth in the future market. However, prod......
Global Celecoxib Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 94
According to our LPI (LP Information) latest study, the global Celecoxib market size was valued at US$ 1243.6 million in 2023. With growing demand in downstream market, the Celecoxib is forecast to a readjusted size of US$ 2232 million by 2030 with a CAGR of 8.7% during review period.
The research report highlights the growth potential of the global Celecoxib market. Celecoxib are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......
Global Ibuprofen Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 100
According to our LPI (LP Information) latest study, the global Ibuprofen market size was valued at US$ 91 million in 2023. With growing demand in downstream market, the Ibuprofen is forecast to a readjusted size of US$ 110.4 million by 2030 with a CAGR of 2.8% during review period.
The research report highlights the growth potential of the global Ibuprofen market. Ibuprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......
Global Ketoprofen Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 94
According to our LPI (LP Information) latest study, the global Ketoprofen market size was valued at US$ 34 million in 2023. With growing demand in downstream market, the Ketoprofen is forecast to a readjusted size of US$ 39 million by 2030 with a CAGR of 2.0% during review period.
The research report highlights the growth potential of the global Ketoprofen market. Ketoprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......
Global Drugs for Sinusitis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 02-Jan-2024 Price: US 3380 Onwards Pages: 114
Market Overview of Global Drugs for Sinusitis market:
According to our latest research, the global Drugs for Sinusitis market looks promising in the next 5 years. As of 2022, the global Drugs for Sinusitis market was estimated at USD 2147.6 million, and it's anticipated to reach USD 3206.59 million in 2028, with a CAGR of 6.91% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Dru......
Global Ibuprofen Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 91
According to our (Global Info Research) latest study, the global Ibuprofen market size was valued at USD 96 million in 2023 and is forecast to a readjusted size of USD 114.4 million by 2030 with a CAGR of 2.6% during review period.
Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation.
Market competitio......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
